Flanders Vaccine Pitch & Match Session

13 Jun 2024 | Park Inn by Radisson Leuven

ImmuneSpec BV

Contract Research Organizations (CRO)

www.immunespec.comNiel, Belgium
1 profile visit

About

ImmuneSpec is  a biotech service provider that offers high-sensitive immunopeptidomics/MAPPS/ligandomics analysis as a service. With our analysis we can identify maximized numbers of MHC I and MHC II associated peptides like neoantigens, tumor associated antigens (for development of immunotherapeutics & PM) but also pathogen derived antigens (for development of prophylactic vaccines) from biological samples. In the context of immunogenicity risk assessment we can deciphere potential T cell epitopes from biotherapeutics for the selection of safe, high efficacy biotherapeutics.

Social media

HEALTH SECTOR

Human healthAnimal healthOne health

RESEARCH AND DEVELOPMENT

Preclinical researchImmunotherapy developmentCell and Gene therapyVaccine developmentmRNA vaccines

THERAPEUTIC AREAS

Infectious diseasesOncologyImmunologyAutoimmune disordersRare diseasesRespiratory diseasesAllergiesCardiovascular diseasesNeurodegenerative diseasesTransplantation

Representatives

Elise Pepermans

CEO & Co-founder

ImmuneSpec